The antiperoxidative activities of nifedipine, verapamil, and diltiazem were compared with that of propranolol by using an in vitro model of sarcolemmal membrane lipid peroxidation. Highly purified sarcolemmal membranes, isolated from canine ventricular myocytes, were peroxidized by a superoxide anion-producing and iron-catalyzed free radical-generating system (dihydroxyfumarate plus FeCI3 and ADP). Lipid peroxidation after 20 minutes of incubation was monitored by malondialdehyde formation. Similar to propranolol, all three calcium blockers exhibited concentration-dependent (10-400 ,M) inhibitory effects against sarcolemmal lipid peroxidation. The order of potency of these agents was nifedipine>propranolol>verapamil> diltiazem. Nifedipine, the most effective calcium blocker, was greater than twofold more potent than propranolol and achieved a significant effect at 10 ,uM. This study suggests that calcium blockers may provide antiperoxidative protection to cardiac membranes. (Circulation Research 1990;66:1449-1452 T he interactions of free radicals in the pathogenesis of cardiovascular ischemia/reperfusion injury have been studied with increasing interest.1-4 The subcellular location of critical free radical events appears to occur at the membrane level; also, since most cardiovascular agents are amphiphilic in nature, many of them are able to partition into the lipid domain of cardiac membranes. Our recent efforts have focused on the effects of membrane-drug interaction(s) on the relative sensitivity of cardiac membranes to free radicals.5-7 Recently, by using the sarcolemmal membrane model, we have documented that certain lipophilic ,3-blockers such as propranolol, pindolol, and metoprolol exhibited significant membrane antiperoxidative activity.6 Of all the /3-blocking agents tested, propranolol was the most potent agent.
The antiperoxidative activities of nifedipine, verapamil, and diltiazem were compared with that of propranolol by using an in vitro model of sarcolemmal membrane lipid peroxidation. Highly purified sarcolemmal membranes, isolated from canine ventricular myocytes, were peroxidized by a superoxide anion-producing and iron-catalyzed free radical-generating system (dihydroxyfumarate plus FeCI3 and ADP). Lipid peroxidation after 20 minutes of incubation was monitored by malondialdehyde formation. Similar to propranolol, all three calcium blockers exhibited concentration-dependent (10-400 ,M) inhibitory effects against sarcolemmal lipid peroxidation. The order of potency of these agents was nifedipine>propranolol>verapamil> diltiazem. Nifedipine, the most effective calcium blocker, was greater than twofold more potent than propranolol and achieved a significant effect at 10 ,uM. This study suggests that calcium blockers may provide antiperoxidative protection to cardiac membranes. (Circulation Research 1990;66:1449-1452) T he interactions of free radicals in the pathogenesis of cardiovascular ischemia/reperfusion injury have been studied with increasing interest.1-4 The subcellular location of critical free radical events appears to occur at the membrane level; also, since most cardiovascular agents are amphiphilic in nature, many of them are able to partition into the lipid domain of cardiac membranes. Our recent efforts have focused on the effects of membrane-drug interaction(s) on the relative sensitivity of cardiac membranes to free radicals. [5] [6] [7] Recently, by using the sarcolemmal membrane model, we have documented that certain lipophilic ,3-blockers such as propranolol, pindolol, and metoprolol exhibited significant membrane antiperoxidative activity.6 Of all the /3-blocking agents tested, propranolol was the most potent agent.
Calcium antagonists are considered to be specific inhibitors of the slow calcium channel.8 It is believed that the major reaction site of these agents is on the plasma membrane or, in the case of the cardiac myocytes, the sarcolemmal membrane.8 These agents, though differing widely in their chemical structure, are lipophilic to various degrees9 and presumably would concentrate in the lipid domains of the phospholipid-rich membranes. In the present study, the relative abilities of three calcium blockers (diltiazem, nifedipine, and verapamil) to affect the susceptibility of the sarcolemmal membrane to free radical injury were examined and compared with that of propranolol.
Materials and Methods
Nifedipine, verapamil, diltiazem, dihydroxyfumarate (DHF), and most other chemicals were purchased from Sigma Chemical, St. Louis, Missouri. Sarcolemmal membranes were prepared from adult canine myocytes as previously described.5'6'10 Briefly, the myocytes, which were isolated from ventricular tissues by collagenase (0.2%) digestion, were disrupted by nitrogen cavitation; the sarcolemmal membranes were enriched by differential and sucrose density centrifugations.
The effects of propranolol and different calcium blockers on free radical-induced lipid peroxidation in the sarcolemma were determined in a buffer consisting of 120 mM KCl, 50 mM sucrose, and 10 mM potassium phosphate, pH 7.2. Sarcolemmal membranes (75-100 g.g protein/ml) were preincubated with each agent initially dissolved in 10 ,ul ethanol/ml and reacted for 10 minutes at 370 C. All samples were incubated under identical oxygen partial pressure of the air, which was monitored by a Clark-type oxygen electrode and was maintained constant throughout the incubation. Initial experiments indicated that longer preincubation periods (up to 30 minutes) did not affect the subsequent results. The peroxidation reactions were initiated by the final addition of 0.025 mM FeCl3-0.250 mM ADP (Fe-ADP) and 0.83 mM DHF. None of the drugs (up to 400 ,uM) showed appreciable effects on the rates of DHF autooxidation measured by the method of Goscin and Fridovich.1" The level of superoxide anions produced in the system was about 3 nmol/ min/ml measured by the superoxide dismutaseinhibitable cytochrome c reduction assay12; this level of production was not affected by the tested drugs within the concentration range of our study. The rates of lipid peroxidation, assayed as malondialdehyde (MDA) formation,6,13 for the control as well as the experimental samples were linear up to at least 30 minutes. Data reported here represent samples incubated for 20 minutes. None of the agents at concentrations less then 400 gM was found to have any nonspecific effect on the MDA assay. Protein determinations were performed according to Lowry et al.14 Statistical differences between groups were determined by unpaired Student's t test.
Results
We have studied the abilities of a few selected 13-blockers and class I antiarrhythmic agents to inhibit lipid peroxidation in isolated sarcolemmal membranes. 6 This work demonstrated that all the ,B-blockers possess various degrees of antiperoxidative activity, and their relative potency correlated with their lipid solubility. Propranolol, being most lipophilic, was the most potent agent. In the present study, the sarcolemmal membranes were pretreated with each of the calcium blockers or propranolol at three selected concentrations for comparison ( Figure  1 ). The antiperoxidative effects of the agents incubated under different conditions were expressed as percent inhibition of the MDA formation compared with controls. The level of MDA formed in the controls was 41.8+3.8 nmol/mg protein (mean of 6±+SD). For comparison, samples incubated in the buffer alone for the same period of time only resulted in 2-3 nmol MDA/mg protein. The results in Figure  1 indicate that all three calcium channel blockers provided concentration-dependent inhibitions of the induced membrane lipid peroxidation; in addition, at any given concentration, the order of the inhibitory activity was nifedipine > propranolol >verapamil > diltiazem. Both nifedipine and propranolol achieved significance (p<0.05 or less) at Values are mean±SD of three to five separate determinations. Sarcolemma were preincubated with the calcium channel blocker(s) for 10 with controls. In additional experiments in which each calcium blocker (200 ,uM) was added with no preincubation, substantially less and inconsistent inhibition of peroxidation was found (data not shown). Such a requirement for a preincubation period suggested that an initial interaction between the drug and membrane phospholipids was essential for the subsequent inhibitory effect.
The relative effective concentrations of each calcium blocker (10-400 ,uM) against membrane lipid peroxidation are presented in the inset (Figure 1 ). All three agents appeared to produce a logarithmic concentration-dependent inhibition of MDA formation. From the linear slopes of the graphs, the concentrations required to inhibit 50% (EC50) of MDA formation were estimated to be 38 ,uM for nifedipine, 206 ,uM for verapamil, and through additional data (not shown), about 850 ,gM for diltiazem.
The arbitrary units calculated for the slope of the curves of nifedipine, verapamil, and diltiazem are 0.695, 0.396, and 0.280, respectively. The differences in slope values suggested that the efficacy order of the calcium blockers was nifedipine>verapamil> diltiazem. The EC50 for propranolol incubated under similar conditions was about 100 ,uM.6 Thus, nifedipine demonstrated 2.5 times the potency of propranolol, whereas verapamil was twofold less and diltiazem was eightfold less potent than propranolol.
In additional experiments, the combined and saturable effects of the calcium blockers were examined. As presented in Table 1 , at a lower concentration (20 ,ttM), combinations oftwo different agents (nifedipine +verapamil, verapamil +diltiazem) resulted in significant (p <0.05) additive inhibitory activities. However, at a relatively high concentration (200 ,uM), combinations of two different agents did not result in any additive effect. The addition of 200 ,uM diltiazem to 200 gtM verapamil did not increase the efficacy beyond that provided by verapamil alone. These data suggest that the agents might bind to common saturable site(s) to mediate the observed effects.
Discussion
As a semiquantitative index of membrane lipid peroxidation, we used the thiobarbituric acid (TBA) assay in our study because of its sensitivity. Due to potential problems of specificity and interference, the assay is not suitable for the study of lipid peroxidation in vivo; however, it remains a useful tool in monitoring relative lipid peroxidation in vitro.1516 With isolated membranes, the intracellular components and metabolic systems that may either affect the MDA formation or interfere with the TBA assay are absent15; thus, it can still be regarded as useful to indicate the relative extent of membrane lipid peroxidation. Our free radical system is an iron-catalyzed one; therefore, both EDTA (except <25 ,uM) and deferoxamine inhibited the reaction. Experiments were performed in which a 10 -fold higher concentration of iron was used; the rate of lipid peroxidation in the controls increased by about 25%. However, the antiperoxidative effects and the order of potency of the agents persisted, suggesting that the observed effects were not due to iron chelating. By using the electron spin resonance spin-trapping procedure similar to that reported recently,7 none of the tested agents (200 ,uM) showed appreciable effects (<10%) on the level of hydroxyl radicals in the system by monitoring 5,5 -dimethyl-l-pyrroline-N-oxide-OH adduct formation. In summary, since both influences of the drugs on the free radical system and nonspecific interference of the TBA assay were ruled out, the results are interpreted to indicate that all calcium blockers tested possess "true" antiperoxidative activities against sarcolemmal lipid peroxidation.
Although the data suggest that initial drugmembrane interactions are essential for the antiperoxidative reaction, the specific mechanism remains to be determined. In contrast to the /3blocking agents, the calcium channel blockers vary markedly in their chemical structure. However, the calcium blockers do have aromatic resonance rings that are capable of stabilizing trapped radicals; most classic chain-breaking antioxidants and ,3blockers have this structure in common. In other studies, nifedipine, verapamil, and propranolol (which has no calcium-blocking activity) protected isolated heart muscle against the deleterious effects of ischemia and reperfusion.17 Because increased production of free radicals has been documented in experimental ischemia followed by reperfusion,34l1819 we submit that the antiperoxidative properties that are common to all three agents might be involved in the protective mechanism.
We speculate that the antiperoxidative mechanism of the calcium blockers might be similar to a chainbreaking reaction at the level of the membrane phospholipids. Because all three agents are lipophilic, it appears likely that they would partition differentially into the cardiac membranes according to their lipophilicity. The reported order of lipid solubility as determined by their partition coefficients in nonmembrane octanol/buffer system was verap-amil>nifedipine>diltiazem.9 However, recent studies of synaptic plasma membranes and liposomes from those membranes indicate that the partition coefficient of nifedipine into native membranes may be higher than that of verapamil.20 In another related study21 with purified cardiac membrane lipid vesicles, it was found that the partition coefficient of dihydropyridine calcium channel antagonists was more than three orders of magnitude higher than that for the nonmembrane octanol/buffer system. Results from all studies show that diltiazem is the least lipid-soluble agent; our results suggest that this property might contribute to its lesser potency against free radical chain reactions in cardiac membranes.
In conclusion, we have demonstrated that calcium blockers possess significant antiperoxidative activities against sarcolemmal lipid peroxidation. However, the clinical relevance of these findings is uncertain. The concentrations (10`M) required to mediate the observed effects were at least 10-fold higher than the therapeutic serum concentrations (10'7-10`6 M) reported for the three calcium blockers.822 On the other hand, due to the higher lipophilicity of certain agents like verapamil, local accumulation into the membrane may be in the millimolar range9; this concentration could provide significant antiperoxidative protection.
